Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)
Sobia Khan·Louise Emmett·Jeff Chen·Hester Lieng·Thomas Eade·Andrew Kneebone·Shraddha Weir·Nathan Papa·Raji Kooner·Jordan Idiare·Kris Rasiah·Bao Ho·Shikha Sharma·Jeremy de Leon·Narjess Ayati·Matthew J Roberts·George Hruby·Keith Wong·James Thompson·Katrina Devitt·George Sidhom·Phillip D. Stricker·Andrew Nguyen·Joanna Olphert
<sup>64</sup>Cu-bisPSMA-PET/CT identifies a higher number of disease recurrences than <sup>68</sup>Ga PSMA-PET/CT with substantial management impact and a high RS true positive rate in men with BCR post RP.
